Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans.

SL, Aspinall; CB, Good; X, Zhao; FE, Cunningham; BB, Heron; M, Geraci; V, Passero; RA, Stone; KJ, Smith; R, Rogers; J, Shields; M, Sartore; DP, Boyle; S, Giberti; J, Szymanski; D, Smith; A, Ha; J, Sessions; S, Depcinski; S, Fishco; I, Molina; T, Lepir; C, Jean; L, Cruz-Diaz; J, Motta; R, Calderon-Vargas; J, Maland; S, Keefe; M, Tague; A, Leone; B, Glovack; B, Kaplan; S, Cosgriff; L, Kaster; I, Tonnu-Mihara; K, Nguyen; J, Carmichael; L, Clifford; K, Lu; G, Chatta

doi:10.1186/s12885-015-1038-y

Public

Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans.

Shared by NobleBlocks on Feb 18, 2015 • 12:00 AM UTC

Authors:

Aspinall SL

Good CB

Zhao X

Abstract

Background Given the paucity of information on dose intensity, the objective of this study is to describe the use of adjuvant chemotherapy for stage III colon cancer, focusing on relative dose intensity (RDI), overall survival (OS) and disease-free survival (DFS).Methods Retrospective cohort of 367 ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!